Fritsche H

No ORCID on file · 3 papers in corpus
2024
Ovarian Cancer surgical consideration is markedly improved by the neural network powered-MIA3G multivariate index assay.
Frontiers in medicine ·doi:10.3389/fmed.2024.1374836

BackgroundSurgery remains the main treatment option for an adnexal mass suspicious of ovarian cancer. The malignancy rate is, however, only 10-15% in women undergoing surgery. This results in a high number of unnecessary surgeries. A survei…

2023
Validation of a deep neural network-based algorithm supporting clinical management of adnexal mass.
Frontiers in medicine ·doi:10.3389/fmed.2023.1102437

BackgroundConservative management of adnexal mass is warranted when there is imaging-based and clinical evidence of benign characteristics. Malignancy risk is, however, a concern due to the mortality rate of ovarian cancer. Malignancy occur…

2007
Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment.
Gynecologic Oncology ·doi:10.1016/j.ygyno.2007.04.022

ObjectivesEarly detection of ovarian cancer should improve overall survival. Multiple serum markers have been evaluated as possible tests to detect early stage disease, but few urine markers have been studied. Mesothelin has been detected i…